Tim Armour is the chairman, CEO and Principal of Capital Research and Management Services. He has been in the business since 1983 and has managed to build his portfolio from the bottom of the ladder to the heights of success that he is enjoying today.
Tim holds a degree in economics from the Middlebury College and was appointed as the chairman to the corporation after the unfortunate demise f the previous chairman. Tim has learned a lot from the world of investing. When he meets with new clients, he always wants to make sure that they understand what it takes to get maximum profits out of any investment banking opportunity.
The company currently has property worth about $1.4 billion in assets and has been doing a lot to improve their performance. It was noted that their performance really took a hit after the death of their previous chairman, but with Tim’s stewardship, things are getting better. Tim deputized James Rothenberg, the late chairman for a long time before he rose to the position. One of the main challenges that he faced when he took up the office was the claim that the company was a little bit too secretive. In a bid to change this, he has tried opening up to the media about the important undertakings of the company.
The company has also organized a few researches about the benefits of actively managing funds. The Capital Group chairman has taken part in the researches, while at the same time improving the sales operations from inside the company. This move is seen as a step towards increasing their long term performance records in some of their main business areas such as The American Mutual Funds.
When he was asked what he thinks about the 21st century investor, he states that the main mistake that they make is looking and chasing after benchmark returns from their investments. He was quick to note that there is the possibility of getting better returns from the investments that one makes and that when the right conditions are in place, success is imperative. Tim has been hailed for his collegiate leadership and is expected to do great for the good of this company in the coming years.
It’s possible to petition the government for a redress of grievances. For this reason, people looking to effect social change will often group people together into a large enough body that a signed petition holds weight. Such petitions can act on governing and corporate bodies to effect change, and it’s a good thing; but Kyle Bass is using this American freedom irresponsibly, and the result could mean decreased liberty for the entire country.
For background, http://usefulstooges.com/2015/08/24/kyle-bass-the-frantic-investments-of-a-desperate-gambler/ is a great article to start with. Otherwise it’s essential to know that Kyle Bass is an Argentine who manages a sketchy hedge fund out of Texas. The fund has had its ups, but the trend tends toward continual decline despite Bass’ increase in mainstream media appearances. Bass hit the financial circuit hard in 2008 when he pointed out America’s poor banking practices would result in an economic implosion. He was right, and people began to listen to him–even though most of what Bass said wasn’t borne by reality. It’s almost as if Bass used his initial prediction as a platform-jump such that he could publicly influence the economy.
It would make sense, because with CAD, Bass is definitely making some influential waves. CAD stands for the Coalition for Affordable Drugs. Basically, this special interest group hoodwinks the infirm and many leftist thinkers into signing petitions and filing lawsuits that are essentially frivolous when all the gloss is removed, but seem legitimate enough to force a court decision. Successfully, CAD has managed to cut costs on a variety of big-ticket pharmaceuticals’ drugs. Sometimes they’ve literally decimated that cost, making the drug 90% less expensive than it was. Sounds great for the infirm and special interest people surrounding CAD, doesn’t it? Until one considers that drop in income predicates a cutting of costs for the pharmaceutical in question, and one of the costs most often cut is Research and Development (R&D), which restricts future discoveries.
Also, when the profit is lost on a drug to such a degree, naturally the company that produces the drug experiences a stock value decrease. Kyle Bass short sells his holdings at this time and makes millions. The scam is completely legal, and completely effective; and that’s why it’s completely frightening, because it has forced congress into a cooperative mode of bipartisanship as they try to rectify Bass’ damages. The end result could be a restricting of previous legal freedoms.
It would make sense if such an aim were Bass’ from the beginning, however, as he has close ties to socialist president Cristina Fernandez de Kirchner, the despotic leader of Argentina. Anyone with ties to a national leader will have access to more information than the casual financier, and this is definitely the case with Bass. Is his hedge fund a front for a socialist campaign bent on destroying prominent companies and legal freedoms in America? Well, that’s not without the realm of possibility.